- Home
- SCOR vs ANEB Comparison
SCOR vs ANEB Comparison
Compare SCOR & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- ANEB
- Stock Information
- Founded
- SCOR 1999
- ANEB 2020
- Country
- SCOR United States
- ANEB United States
- Employees
- SCOR N/A
- ANEB N/A
- Industry
- SCOR Business Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- ANEB Health Care
- Exchange
- SCOR Nasdaq
- ANEB Nasdaq
- Market Cap
- SCOR 37.1M
- ANEB 111.8M
- IPO Year
- SCOR 2007
- ANEB 2021
- Fundamental
- Price
- SCOR $7.82
- ANEB $2.43
- Analyst Decision
- SCOR
- ANEB Buy
- Analyst Count
- SCOR 0
- ANEB 2
- Target Price
- SCOR N/A
- ANEB $8.00
- AVG Volume (30 Days)
- SCOR 15.4K
- ANEB 22.0K
- Earning Date
- SCOR 11-04-2025
- ANEB 11-14-2025
- Dividend Yield
- SCOR N/A
- ANEB N/A
- EPS Growth
- SCOR N/A
- ANEB N/A
- EPS
- SCOR N/A
- ANEB N/A
- Revenue
- SCOR $358,940,000.00
- ANEB N/A
- Revenue This Year
- SCOR $3.45
- ANEB N/A
- Revenue Next Year
- SCOR $2.59
- ANEB N/A
- P/E Ratio
- SCOR N/A
- ANEB N/A
- Revenue Growth
- SCOR 0.77
- ANEB N/A
- 52 Week Low
- SCOR $4.39
- ANEB $0.80
- 52 Week High
- SCOR $10.18
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- SCOR 53.28
- ANEB 37.07
- Support Level
- SCOR $7.37
- ANEB $2.44
- Resistance Level
- SCOR $7.67
- ANEB $2.65
- Average True Range (ATR)
- SCOR 0.51
- ANEB 0.08
- MACD
- SCOR -0.06
- ANEB -0.04
- Stochastic Oscillator
- SCOR 81.25
- ANEB 5.56
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.